Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $16.98 Billion |
|---|---|
| Enterprise Value | $325.36 Billion |
| Annual dividend | $0.49 |
| Dividend yield | 2.46% |
| Earnings per Share | $242.87 |
| Beta | 0.03 |
| Outstanding Shares | 851,520,000 |
| P/E Ratio | 11.19 |
|---|---|
| PEG | -22.08 |
| Price to Sales | 0.03 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 0.51 |
| Enterprise Value to EBIT | 1.47 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 2.11 |
| Debt to Equity | 0.39 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Shionogi & Co., Ltd., an Osaka, Japan-based pharmaceutical company established in 1878, focuses on the discovery, development, production, and commercialization of medicines, diagnostic tools, and medical devices primarily within Japan. ...